We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
85 hedge funds and large institutions have $330M invested in Atara Biotherapeutics in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
94% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 18
13% more funds holding
Funds holding: 75 → 85 (+10)
3.22% more ownership
Funds ownership: 0% → 3.22% (+3.2%)
31% less capital invested
Capital invested by funds: $477M → $330M (-$147M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
85
Holders Change
+10
Holders Change %
+13.33%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
35
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$11M |
| 2 |
AG
Artal Group
Luxembourg
|
+$4.66M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.07M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.92M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.65M |
